These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 9313636

  • 1. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
    Slater CR, Young C, Wood SJ, Bewick GS, Anderson LV, Baxter P, Fawcett PR, Roberts M, Jacobson L, Kuks J, Vincent A, Newsom-Davis J.
    Brain; 1997 Sep; 120 ( Pt 9)():1513-31. PubMed ID: 9313636
    [Abstract] [Full Text] [Related]

  • 2. Congenital myasthenic syndromes in two kinships with end-plate acetylcholine receptor and utrophin deficiency.
    Sieb JP, Dörfler P, Tzartos S, Wewer UM, Rüegg MA, Meyer D, Baumann I, Lindemuth R, Jakschik J, Ries F.
    Neurology; 1998 Jan; 50(1):54-61. PubMed ID: 9443457
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'.
    Slater CR, Fawcett PR, Walls TJ, Lyons PR, Bailey SJ, Beeson D, Young C, Gardner-Medwin D.
    Brain; 2006 Aug; 129(Pt 8):2061-76. PubMed ID: 16870884
    [Abstract] [Full Text] [Related]

  • 6. Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations.
    Sieb JP, Kraner S, Rauch M, Steinlein OK.
    Hum Genet; 2000 Aug; 107(2):160-4. PubMed ID: 11030414
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. How myasthenia gravis alters the safety factor for neuromuscular transmission.
    Ruff RL, Lennon VA.
    J Neuroimmunol; 2008 Sep 15; 201-202():13-20. PubMed ID: 18632162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities].
    Yoshimura T, Motomura M, Tsujihata M.
    Brain Nerve; 2011 Jul 15; 63(7):719-27. PubMed ID: 21747142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
    Serra A, Ruff R, Kaminski H, Leigh RJ.
    Ann N Y Acad Sci; 2011 Sep 15; 1233():26-33. PubMed ID: 21950972
    [Abstract] [Full Text] [Related]

  • 17. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R, Vincent A.
    Exp Neurol; 2012 Apr 15; 234(2):506-12. PubMed ID: 22326541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.